- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02540616
Transcranial Electrical Stimulation for Mal de Debarquement Syndrome
The goal of this study is to determine whether external neuromodulation using transcranial electrical stimulation (TES) can reduce the perception of self-motion that is experienced by patients with MdDS. Mal de debarquement is translated as the "sickness of disembarkment," and refers to the chronic feeling of rocking dizziness that occurs after exposure to passive motion. A similar form of rocking dizziness can be experienced without a motion trigger in individuals with certain risk factors.
Treatment for MdDS is limited and morbidity is high.The goal of the study is to determine whether TES can suppress the rocking dizziness of MdDS either as a standalone therapy or as an adjunctive therapy to other forms of neuromodulation such as transcranial magnetic stimulation. The investigators will determine the optimal treatment duration and stimulation parameters.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Eligible participants who meet study criteria and pass the safety screen will be invited to participate in the study. If TES is used as add-on treatment to repetitive transcranial magnetic stimulation (rTMS), the training for TES application will be done on-site. However, in a portion of the study that does not involve rTMS, remote training will be performed via a webcam provided that a suitable "Study Buddy" is available to assist the participant.
Participants will maintain web-based diaries of their symptoms for up to four weeks prior to treatment with TES. Before the actual treatment sessions are started, the subjects will complete baseline questionnaires online which will be repeated once a week for up to 12 weeks. Over the course of the study, the subjects will also keep a daily log of their sessions such as how many sessions they performed, for how long, and whether they had any side effects with each session.
The studies will include a sham arm, allocated at a ratio of 1:1. On-site studies will involve the application of EEG, MRI, balance, cognitive, and visual/auditory stimulation tests.
Study Type
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Minnesota
-
Minneapolis, Minnesota, United States, 55414
- University of Minnesota
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age ≥18 years old
- Willing and capable of interacting with the informed consent process
- Primary disorder being a persistent perception of motion with no other cause determined after a careful interview.
- Able to identity a study buddy and provide contact information
Exclusion Criteria:
- Subjects who cannot comply with study conditions.
- Active psychiatric condition such as mania or psychosis
- Unstable medical condition
- Implanted metal in the head or neck (metal or shrapnel, deep brain stimulators, aneurysm clips, cochlear stimulators, retinal implants, etc). Dental fillings are acceptable.
- Any active skin disorder that affects skin integrity of the scalp.
- Pregnant
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Transcranial Electrical Stimulation-Real
The participant will perform real TES.
The forms of TES used in this study will include transcranial direct current stimulation (tDCS), transcranial alternating current stimulation (tACS), or transcranial random noise stimulation (tRNS).
Each stimulation session will last for 20-minutes.
|
A form of external neuromodulation using electrodes on the surface of the head.
We will be using the TCT tDCS device (www.trans.cranial.com)
or devices constructed by our research group or collaborators.
Other Names:
|
Sham Comparator: Transcranial Electrical Stimulation-Sham
The participant will perform sham TES for 20-minutes.
The form of sham TES will depend on the active arm, e.g. if tACS is on the active arm, then the sham tACS will be a different frequency of stimulation.
If tDCS is the active arm, then a short ramp up of tDCS followed by a ramp down (about 60-seconds) will be used as the sham arm.
|
A form of external neuromodulation using electrodes on the surface of the head.
We will be using the TCT tDCS device (www.trans.cranial.com)
or devices constructed by our research group or collaborators.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Dizziness Handicap Inventory
Time Frame: 10 years
|
This is a well validated 100 point self-reported scale with Functional, Physical, and Emotional components.
|
10 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mal de Debarquement Balance Rating Scale
Time Frame: 10 years
|
This is a 10 point self-reported scale that assesses the severity of rocking dizziness and its effect on balance function.
|
10 years
|
Hospital Anxiety and Depression Scale
Time Frame: 10 years
|
This is a well validated 42 point self-reported scale of anxiety and dizziness.
|
10 years
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
SF-12
Time Frame: 10 years
|
Well established Quality of Life Scale
|
10 years
|
Motion Sickness Susceptibility Scale
Time Frame: 10 years
|
Measures motion sickness susceptibility before and after age 12
|
10 years
|
Neo-Five Factor Inventory
Time Frame: 10 years
|
Quantifies the five major personality traits
|
10 years
|
Empathy Quotient
Time Frame: 10 years
|
40 item online or 20 item abbreviated scale to determine strength of empathic traits
|
10 years
|
Functional Activities Scale
Time Frame: 10 years
|
Measures comfort with doing some basic activities of daily living
|
10 years
|
Memory Questionnaire
Time Frame: 10 years
|
Measures subjective impressions of prospective and retrospective memory
|
10 years
|
Multidimensional Fatigue Inventory
Time Frame: 10 years
|
Measures general, physical, and mental fatigue
|
10 years
|
Edinburgh Handedness Scale
Time Frame: 10 years
|
Standard measure of handedness
|
10 years
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Yoon-Hee Cha, MD, University of Minnesota
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2013-006-01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mal de Debarquement Syndrome
-
Icahn School of Medicine at Mount SinaiNational Institute on Deafness and Other Communication Disorders (NIDCD)CompletedMal de Debarquement Syndrome (MdDS)United States
-
Icahn School of Medicine at Mount SinaiNew York University; National Institute on Deafness and Other Communication... and other collaboratorsRecruiting
-
University of MinnesotaCompletedMal de Debarquement SyndromeUnited States
-
University of MinnesotaWithdrawnMal de Debarquement Syndrome
-
Riphah International UniversityRecruitingDe Quervain SyndromePakistan
-
National University Hospital, SingaporeNot yet recruitingDe Quervain Syndrome
-
Mayo ClinicTerminatedCornelia de Lange SyndromeUnited States
-
Johns Hopkins UniversityCornelia de Lange Syndrome FoundationNot yet recruitingCornelia de Lange SyndromeUnited States
-
Washington University School of MedicineRecruitingLong QT Syndrome | Torsades de Pointe Caused by DrugUnited States
-
Hugo W. Moser Research Institute at Kennedy Krieger...RecruitingCornelia de Lange SyndromeUnited States
Clinical Trials on Transcranial Electrical Stimulation
-
Spaulding Rehabilitation HospitalHighland Instruments, Inc.Active, not recruitingOsteoarthritis | Chronic PainUnited States
-
Beth Israel Deaconess Medical CenterRecruitingPsychosis | Hallucinations, AuditoryUnited States
-
The University of New South WalesCompletedBipolar Disorder | Major Depressive DisorderAustralia
-
University of NebraskaNational Institute of Mental Health (NIMH)CompletedHow Occipital tDCS Affects Brain Function in Healthy AdultsUnited States
-
Centre Hospitalier Universitaire, AmiensRecruitingEpilepsy | Children | tDCS | Transcranial Electric Stimulation | Pharmacoresistant | HR EEGFrance
-
Northwestern UniversityNational Institute on Deafness and Other Communication Disorders (NIDCD)CompletedTinnitus, SubjectiveUnited States
-
Northwestern UniversityBrain & Behavior Research FoundationCompleted
-
University of Alabama at BirminghamCompleted
-
Istanbul UniversityCompletedPanic DisorderTurkey
-
Istanbul UniversityCompletedParkinson DiseaseTurkey